We * - *
show * - *
here * - *
that * - *
in * - *
addition * - *
to * - *
sigma * - *
s * - *
, * - *
the * - *
global * - *
regulators * - *
Lrp (PTE*) - (A0*)
, * - *
cyclic * - *
AMP * - *
( * - *
cAMP * - *
) * - *
receptor * - *
protein-cAMP * - *
complex * - *
( * - *
cAMP-CRP (PTE*) - *
) * - *
, * - *
and * - *
integration * - *
host * - *
factor * - *
( * - *
IHF (PTE*) - *
) * - *
are * - *
involved * involve (V*)
in * - *
the (PRC* - (A4*
control *) - *)
of * - *
osmY * - *
. * - *

Use * - *
of * - *
gene (EXP* - *
fusions *) - *
to * - *
study * - *
expression * express (V*)
of * - *
cysB (DNA*) - (A0*)
, * - *
the * - *
regulatory * - *
gene * - *
of * - *
the * - *
cysteine * - *
regulon * - *
. * - *

The * - *
regulation * regulation (V*)
of * - *
the (DNA* - (A0*
two * - *
divergent * - *
promoters *) - *)
is * - *
thus * - *
simultaneously * - *
controlled * - *
not * - *
only * - *
by * - *
the (PTE* - *
cAMP-CAP * - *
complex *) - *
, * - *
a * - *
global * - *
regulator * - *
, * - *
but * - *
also * - *
by * - *
a (PTE* - *
specific * - *
regulator *) - *
of * - *
arginine * - *
metabolism * - *
, * - *
suggesting * - *
a * - *
previously * - *
unsuspected * - *
link * - *
between * - *
carbon * - *
metabolism * - *
and * - *
translation * - *
initiation * - *
. * - *

The (DNA* - (A1*
fadL * - *
gene *) - *)
of * - *
Escherichia * - *
coli * - *
codes * code (V*)
for * - *
an (PTE* - (A0*
outer * - *
membrane * - *
protein *) - *)
that * - *
is * - *
involved * - *
in * - *
the * - *
uptake * - *
of * - *
long-chain * - *
fatty * - *
acids * - *
. * - *

The * - * * *
inducer * - * * *
for * - * * *
the * - * * *
CytR (PTE*) - (A1*) * *
repressor * - * * *
, * - * * *
cytidine * - * (A1*) *
, * - * * *
does * - * * *
not * - * * *
prevent * - * * *
in * - (A3* * *
vitro * - *) * *
DNA (DNA*) - (A7*) * *
binding * bind (V*) * *
of * - * * *
CytR * - * * *
, * - * * *
but * - * * *
releases * release * (V*) *
the (PTE* - * (A0* *
repressor *) - * *) *
from * - * * *
the (PTE* - * (A6* *
nucleoprotein * - * * *
complex *) - * *) *
and * - * * *
leaves * - * * *
the (PTE* - * * (A1*
cAMP-CRP * - * * *
activator *) - * * *)
bound * bound * * (V*)
to * - * * *
its (DNA* - * * (A7*
two * - * * *
DNA * - * * *
targets *) - * * *)
. * - * * *

The * - *
regulation * regulation (V*)
of * - *
gcvA (DNA*) - (A0*)
was * - *
examined * - *
by * - *
constructing * - *
a * - *
gcvA-lacZ * - *
gene * - *
fusion * - *
in * - *
which * - *
beta-galactosidase * - *
synthesis * - *
is * - *
under * - *
the * - *
control * - *
of * - *
the * - *
gcvA * - *
regulatory * - *
region * - *
. * - *

The (DNA* - (A1*
cpxA101 * - *
mutation *) - *)
abolishes * abolish (V*)
cpxA (PTE* - (A0*
phosphatase * - *
activity *) - *)
and * - *
results * - *
in * - *
the * - *
accumulation * - *
of * - *
phosphorylated * - *
CpxR * - *
. * - *

Two * - *
regulatory * - *
proteins * - *
, * - *
Gal (PTE* - *
repressor * - *
and * - *
isorepressor *) - *
, * - *
control * - *
the * - *
expression * express (V*)
of * - *
the (DNA* - (A0*
gal * - *
and * - *
mgl * - *
operons *) - *)
in * - (A2*
Escherichia (ORG* - *
coli *) - *)
. * - *

The * - *
presence * - *
of * - *
two * - *
predominant * - *
NERF * - *
transcripts * - *
in * - *
various * - *
fetal * - *
and * - *
adult * - *
human * - *
tissues * - *
is * - *
due * - *
to * - *
at * - *
least * - *
three * - *
alternative * - *
splice * - *
products * - *
, * - *
NERF-1a * - *
, * - *
NERF-1b * - *
, * - *
and * - *
NERF-2 * - *
, * - *
which * - *
differ * - *
in * - *
their * - *
amino * - *
termini * - *
and * - *
their * - *
expression * express (V*)
in * - (A2*
different (ORG* - *
tissues *) - *)
. * - *

Site-directed * - *
mutagenesis * - *
of * - *
the * - *
crp * - *
binding * - *
site * - *
provided * - *
evidence * - *
that * - *
this * - *
site * - *
is * - *
necessary * - *
for * - *
the * - *
in * - *
vivo * - *
regulation * - *
of * - *
ompB (DNA*) - (A0*)
expression * express (V*)
by * - *
cyclic (EXP* - *
AMP *) - *
. * - *

Expression * express (V*)
from * - *
the * - *
Escherichia * - *
coli * - *
nrfA * - *
promoter * - *
( * - *
pnrfA (DNA*) - (A6*)
) * - *
is * - *
activated * - *
by * - *
both * - *
the (PTE* - *
FNR * - *
protein *) - *
( * - *
an * - *
anaerobically * - *
triggered * - *
transcription * - *
activator * - *
) * - *
and * - *
the (PTE* - *
NarL * - *
or * - *
NarP * - *
proteins *) - *
( * - *
transcription * - *
activators * - *
triggered * - *
by * - *
nitrite * - *
and * - *
nitrate * - *
) * - *
. * - *

Among * - *
the * - *
conditions * - *
tested * - *
( * - *
carbon (EXP* - *
starvation *) - *
, * - *
the (EXP* - *
stringent * - *
response *) - *
, * - *
phosphate (EXP* - *
starvation *) - *
, * - *
and * - *
the (EXP* - *
SOS * - *
response *) - *
) * - *
, * - *
only * - *
phosphate (EXP* - *
depletion *) - *
increased * - *
iciA (DNA*) - (A0*)
expression * express (V*)
. * - *

It * - (A0*)
involves * involve (V*)
two * - *
upstream * - *
regulatory * - *
sequences * - *
, * - *
one * - *
between * - *
the * - *
hyp * - *
and * - *
the * - *
hyc * - *
operon * - *
( * - *
IR1 (DNA*) - (A4*)
) * - *
, * - *
and * - *
the * - *
other * - *
between * - *
hycA * - *
and * - *
hycB * - *
( * - *
IR2 (DNA*) - *
) * - *
. * - *

We * - * *
suggest * - * *
that * - * *
NarL (DNA*) - * *
interferes * - * *
with * - * *
IHF (PTE*) - (A0*) *
binding * bind (V*) *
at * - * *
the * - * *
nir * - * *
promoter * - * *
by * - * *
distorting * - * *
the * - * *
minor * - * *
groove * - * *
at * - * *
its * - * *
target * - * *
site * - * *
, * - * *
and * - * *
we * - * *
argue * - * *
that * - * *
the * - * *
resulting * - * *
activation * - * *
by * - * *
NarL * - * *
results * - * *
from * - * *
remodelling * - * *
of * - * *
the * - * *
local * - * *
nucleoprotein * - * *
structure * - * *
to * - * *
facilitate * - * *
FNR-dependent * - * (A5*)
transcription * transcription * (V*)
. * - * *

In * - * *
addition * - * *
, * - * *
the (DNA* - (A0* *
cluster *) - *) *
contains * contain (V*) *
other (DNA* - (A4* (A0*
promoters *) - *) *)
individually * - * (A5*)
regulated * regulate * (V*)
by * - * *
cis- * - * (A1*
and * - * *
trans-acting * - * *
signals * - * *)
. * - * *

Erythroid * - *
Kr√ºppel-like * - *
factor * - *
( * - *
EKLF * - *
) * - *
is * - *
necessary * - *
for * - *
stage-specific * - (A5*)
expression * express (V*)
of * - *
the (DNA* - (A0*
human * - *
beta-globin * - *
gene *) - *)
. * - *

These * - * *
findings * - * *
suggest * - * *
that * - * *
the * - * *
role * - * *
of * - * *
the * - * *
rearrangements * - * *
fusing * - * *
RLF (DNA* - (A1* *
and * - * *
L-myc *) - *) *
is * - * *
to * - * *
deregulate * deregulate (V*) *
the * - (A0* *
tightly * - * (A5*
controlled * - * *)
expression * express * (V*)
of * - * *
the (DNA* - * (A0*
L-myc * - * *
gene *) - *) *)
. * - * *

In * - * * * *
vitro * - * * * *
DNase * - * * * *
I * - * * * *
protection * - * * * *
experiments * - * * * *
indicated * - * * * *
that * - * * * *
among * - * * * *
operators * - * * * *
of * - * * * *
the * - * * * *
gal * - * * * *
regulon * - * * * *
, * - * * * *
GalS (PTE*) - (A1*) * * *
binds * bind (V*) * * *
most * - * * * *
strongly * - * * * *
to * - * * * *
the (DNA* - (A0* * * *
external * - * * * *
operator *) - *) * * *
of * - * * * *
the (DNA* - * (A1* * *
mgl * - * * * *
operon *) - * *) * *
, * - * * * *
which * - * * * *
encodes * encode * (V*) * *
the (PTE* - * (A0* * *
high-affinity * - * * * *
beta-methylgalactoside * - * * * *
galactose * - * * * *
transport * - * * * *
system *) - * *) * *
, * - * * * *
and * - * * * *
with * - * * * *
less * - * * * *
affinity * - * * * *
to * - * * * *
the (DNA* - * * * *
operators *) - * * * *
controlling * - * * * *
expression * express * * (V*) *
of * - * * * *
the (DNA* - * * (A0* (A1*
gal * - * * * *
operon *) - * * *) *)
, * - * * * *
which * - * * * *
codes * code * * * (V*)
for * - * * * *
enzymes (PTE*) - * * * (A0*)
of * - * * * *
galactose * - * * * *
metabolism * - * * * *
. * - * * * *

The * - * *
expression * express (V*) *
levels * - * *
of * - * *
the * - * *
electron * - * *
transfer * - * *
chain * - * *
genes * - * *
, * - * *
nuoA (DNA*) - (A0*) *
, * - * *
ndh (DNA*) - * *
, * - * *
and * - * *
ubiE (DNA*) - * *
, * - * *
were * - * *
not * - * *
significantly * - * *
affected * - * *
by * - * *
either * - * *
ArcA (PTE*) - * *
or * - * *
Fnr (PTE* - * *
regulation * - * *
proteins *) - * *
, * - * *
while * - * *
a * - * *
lower * - * *
expression * express * (V*)
of * - * *
cydA (DNA*) - * (A0*)
( * - * *
up * - * *
to * - * *
9-fold * - * (A9*
lower * - * *)
) * - * *
and * - * *
a * - * *
higher * - * *
expression * - * *
of * - * *
cyoA * - * *
( * - * *
up * - * *
to * - * *
31-fold * - * *
higher * - * *
) * - * *
were * - * *
observed * - * *
in * - * *
cultures * - * *
of * - * *
the * - * *
arcA * - * *
mutant * - * *
strain * - * *
compared * - * *
to * - * *
those * - * *
of * - * *
the * - * *
wild * - * *
type * - * *
. * - * *

Cotransfections * cotransfect (V*) * * *
with * - * * * *
plasmids (DNA*) - (A0*) (A1*) * *
expressing * express * (V*) * *
WT-1 (DNA*) - * (A0*) * *
, * - * * * *
WTAR (DNA*) - * * * *
( * - * * * *
a (DNA* - * * * *
mutated * - * * * *
form *) - * * * *
of * - * * * *
WT-1 (DNA*) - * * (A3*) *
) * - * * * *
, * - * * * *
p53 (DNA*) - * * * *
, * - * * * *
and * - * * * *
a * - * * * *
mutated * - * * * *
form * - * * * *
of * - * * * *
p53 * - * * * *
revealed * - * * * *
a * - * * * *
complex * - * * * *
pattern * - * * * *
of * - * * * *
regulation * - * * * *
with * - * * * *
a * - * * * *
3-fold * - * * (A9*) *
induction * induce * * (V*) *
with * - * * * *
WT-1 * - * * * *
, * - * * * *
a * - * * * *
7-fold * - * * * *
induction * - * * * *
with * - * * * *
mutated (DNA* - * * * *
p53 *) - * * * *
, * - * * * *
and * - * * * *
a * - * * * *
4-fold * - * * * (A9*)
repression * repress * * * (V*)
with * - * * * *
wild-type (DNA* - * * * (A3*
p53 *) - * * * *)
. (PRC*) - * * * *

The * - (A1*
coactivator * - *
activity * - *)
requires * require (V*)
an (PTE* - (A0*
hTAF * - *
( * - *
II * - *
) * - *
135 * - *
region *) - *)
that * - *
is * - *
located * - *
between * - *
the * - *
conserved * - *
domains * - *
but * - *
is * - *
itself * - *
not * - *
conserved * - *
in * - *
dTAF * - *
( * - *
II * - *
) * - *
110 * - *
and * - *
hTAF * - *
( * - *
II * - *
) * - *
105 * - *
. * - *

The (DNA* - (A1* *
cspA * - * *
and * - * *
fecR * - * *
genes *) - *) *
, * - * *
encoding * encode (V*) *
regulatory (PTE* - (A0* *
proteins *) - *) *
responding * - * *
to * - * *
cold * - (A3* *
shock * - *) *
and * - * *
to * - * *
iron (EXP*) - * *
, * - * *
respectively * - * *
, * - * *
and * - * *
yoaD (DNA*) - * (A1*)
, * - * *
encoding * encode * (V*)
a (PTE* - * (A0*
putative * - * *
negative * - * *
regulator *) - * *)
of * - * *
cellulose * - * *
biosynthesis * - * *
, * - * *
were * - * *
found * - * *
to * - * *
be * - * *
some * - * *
of * - * *
the * - * *
novel * - * *
CsgD-regulated * - * *
genes * - * *
. * - * *

Two (DNA* - (A1*
acnA * - *
promoters *) - *)
transcribing * transcribe (V*)
from * - *
start * - *
points * - *
located * - *
407 * - *
bp * - *
( * - *
P1acnA (DNA*) - (A6*)
) * - *
and * - *
50 * - *
bp * - *
( * - *
P2acnA (DNA*) - *
) * - *
upstream * - *
of * - *
the * - *
acnA * - *
coding * - *
region * - *
, * - *
and * - *
one * - *
acnB * - *
promoter * - *
( * - *
PacnB * - *
) * - *
with * - *
a * - *
start * - *
point * - *
95 * - *
bp * - *
upstream * - *
of * - *
the * - *
acnB * - *
coding * - *
region * - *
, * - *
were * - *
identified * - *
by * - *
primer * - *
extension * - *
analysis * - *
. * - *

The * - *
ArC/XylS * - *
family * - *
of * - *
prokaryotic * - *
positive * - *
transcriptional * - *
regulators * - *
includes * - *
more (PTE* - (A0*
than * - *
100 * - *
proteins * - *
and * - *
polypeptides *) - *)
derived * derive (V*)
from * - *
open (DNA* - (A6*
reading * - *
frames *) - *)
translated * - *
from * - *
DNA * - *
sequences * - *
. * - *

In * - *
vitro * - *
experiments * - *
with * - *
GadE (PTE* - (A1*
purified * - *
protein *) - *)
provided * - *
evidence * - *
that * - *
this * - *
regulator * - *
binds * bind (V*)
to * - *
the (DNA* - (A7*
promoter * - *
region *) - *)
of * - *
these * - *
target * - *
genes * - *
. * - *

Overexpression * overexpress (V*) *
of * - * *
marA * - * *
alone * - * *
on * - (A2* *
a (DNA* - * *
multicopy * - * *
plasmid *) - *) *
caused * - * *
high * - * (A5*
constitutive * - * *)
expression * express * (V*)
of * - * *
inaA (DNA*) - * (A0*)
in * - * *
a (None* - * *
strain *) - * *
with * - * *
an * - * *
extensive * - * *
( * - * *
39-kbp * - * *
) * - * *
marRAB * - * *
deletion * - * *
. (DNA*) - (A0*) *

By * - * *
using * - * *
the * - * *
DNase * - * *
I * - * *
footprinting * - * *
technique * - * *
, * - * *
we * - * *
showed * - * *
that * - * *
CRP (PTE*) - (A1*) (A1*)
binds * bind (V*) (V*)
with * - * *
high * - (A5* *
affinity * - *) *
to * - * *
the (DNA* - (A7* *
three * - * *
malEp-proximal * - * *
sites *) - *) *
and * - * *
with * - * *
a * - * (A5*
low * - * *
affinity * - * *)
to * - * *
the (DNA* - * (A7*
fourth * - * *
site *) - * *)
. * - * *

The (DNA* - (A0* (A1* *
DNA *) - *) *) *
containing * contain (V*) * *
these (DNA* - (A4* * *
two * - * * *
operators *) - *) * *
synergistically * - * (A5*) *
increased * increase * (V*) *
the * - * (A0* *
apparent * - * * *
affinity * - * *) *
of * - * * *
glp * - * * *
repressor * - * * *
for * - * * *
DNA (DNA* - * * (A0*
fragments *) - * * *)
containing * contain * * (V*)
the (DNA* - * * (A4*
four * - * * *
operators *) - * * *)
in * - * * (A2*
the (DNA* - * * *
promoter * - * * *
region *) - * * *)
of * - * * *
the * - * * *
glpFK * - * * *
operon * - * * *
. * - * * *

Control * control (V*) *
of * - * *
the (DNA* - (A0* *
ompB * - * *
operon *) - *) *
by * - * *
cyclic (PTE* - (A1* *
AMP-CRP *) - *) *
may * - * *
account * - * *
for * - * *
the * - * *
observed * - * *
regulation * - * *
of * - * *
the * - * *
formation * form * (V*)
of * - * *
OmpF (PTE* - * (A0*
and * - * *
OmpC *) - * *)
by * - * *
this (PTE* - * (A1*
complex *) - * *)
( * - * *
N * - * *
. * - * *
W * - * *
. * - * *
Scott * - * *
and * - * *
C * - * *
. * - * *
R * - * *
. * - * *
Harwood * - * *
, * - * *
FEMS * - * *
Microbiol * - * *
. * - * *
Lett * - * *
. * - * *
9 * - * *
: * - * *
95-98 * - * *
, * - * *
1980 * - * *
) * - * *
. * - * *

The * - (A1* * * * *
control * - * * * * *
loop * - *) * * * *
involves * involve (V*) * * * *
the (PTE* - (A0* * * * *
GadX * - * * * * *
protein *) - *) * * * *
repressing * - * * * * *
the * - * * * * *
expression * express * (V*) * * *
of * - * * * * *
gadW (DNA*) - * (A0*) * * *
and * - * * * * *
the (PTE* - * * (A1* (A1* *
GadW * - * * * * *
protein *) - * * *) *) *
repressing * repress * * (V*) * *
or * - * * * * *
inhibiting * inhibit * * * (V*) *
RpoS (PTE*) - * * (A0*) (A0*) *
, * - * * * * *
which * - * * * * *
is * - * * * * *
the (PTE* - * * * * *
alternative * - * * * * *
sigma * - * * * * *
factor *) - * * * * *
that * - * * * * *
drives * - * * * * *
transcription * transcription * * * * (V*)
of * - * * * * *
gadX (DNA*) - * * * * (A0*)
. * - * * * * *

We * - *
have * - *
identified * - *
a * - *
novel * - *
regulator * - *
, * - *
termed * - *
MlrA (PTE*) - (A1*)
, * - *
that * - *
is * - *
required * require (V*)
for * - *
curli * - (A11*
production * - *)
and * - *
extracellular * - *
matrix * - *
formation * - *
. * - *

Superimposed * - * *
in * - * *
the * - * *
specific * - * *
PaaX-mediated * - (A5*) *
regulation * regulation (V*) *
is * - * *
transcriptional * - * (A5*)
activation * activate * (V*)
by * - * *
the (PTE* - * (A1*
cAMP * - * *
receptor * - * *
protein *) - * *)
and * - * *
the (PTE* - * *
integration * - * *
host * - * *
factor * - * *
protein *) - * *
. * - * *

Therefore * - * *
, * - * *
it * - * *
seems * - * *
that * - * *
different * - (A1* (A1*
mechanisms * - *) *)
involving * involve (V*) *
RpoS (PTE* - (A8* *
and * - * *
ppGpp *) - *) *
regulate * regulate * (V*)
the * - * (A0*
growth-phase * - * *
response * - * *)
of * - * *
the * - * *
two * - * *
promoters * - * *
. * - * *

Homocysteine (EXP*) - *
, * - *
a * - *
coregulator * - *
for * - *
MetR (PTE*) - (A1*)
, * - *
increased * - *
MetR * - *
binding * bind (V*)
to * - *
the (DNA* - (A7*
glyA * - *
control * - *
region *) - *)
. * - *

Normal * - *
expression * express (V*)
of * - *
fimA (DNA*) - (A0*)
was * - *
shown * - *
to * - *
require * - *
the * - *
integration * - *
host * - *
factor * - *
( * - *
IHF (PTE*) - *
) * - *
. * - *

Strains (None*) - *
unable * - *
to * - *
synthesize * - *
any * - *
one * - *
of * - *
the * - *
NarL * - *
, * - *
NarP * - *
, * - *
NarQ * - *
, * - *
or * - *
NarX * - *
proteins * - *
, * - *
but * - *
retaining * - *
the * - *
capacity * - *
to * - *
synthesize * - *
the * - *
remaining * - *
three * - *
, * - *
exhibited * - *
essentially * - *
normal * - *
nitrate (EXP*) - (A1*)
regulation * regulation (V*)
. * - *

HOX4C (PTE* - (A0* (A1*
and * - * *
HOX4D * - * *
proteins *) - *) *)
synthesized * synthesize (V*) *
in * - (A2* *
bacteria * - *) *
bind * bind * (V*)
to * - * *
the (DNA* - * (A7*
same * - * *
conserved * - * *
sequence *) - * *)
located * - * *
around * - * *
position * - * *
-120 * - * *
, * - * *
as * - * *
well * - * *
as * - * *
to * - * *
the (DNA* - * *
TATA * - * *
box *) - * *
and * - * *
immediately (DNA* - * *
upstream * - * *
and * - * *
downstream * - * *
nucleotides *) - * *
. (ORG*) - * *

Analyses * - * * *
to * - * * *
quantitate * - * * *
the * - * * *
induction * induce (V*) * *
of * - * * *
this * - (A0* * *
system * - *) * *
show * - * * *
that * - * * *
derepression * derepress * (V*) *
of * - * * *
the (DNA* - * (A0* *
operon *) - * *) *
is * - * * *
first * - * * *
detectable * - * * *
5 * - * * *
min * - * * *
after * - * * *
UV * - * * *
exposure * - * * *
, * - * * *
with * - * * *
the * - * * (A0*
rate * - * * *
of * - * * *
synthesis * - * * *)
increasing * increase * * (V*)
to * - * * *
four * - * * (A9*
to * - * * *
six * - * * *
times * - * * *
the * - * * *
uninduced * - * * *
rate * - * * *)
during * - * * *
the * - * * *
subsequent * - * * *
30 * - * * *
min * - * * *
. * - * * *

When * - * * *
expressed * express (V*) * *
in * - (A2* * *
COS (ORG* - * * *
cells *) - *) * *
, * - * * *
however * - * * *
, * - * * *
NFAT1 (PTE*) - * (A0*) *
is * - * * *
capable * - * * *
of * - * * *
transactivation * - * * *
, * - * * *
but * - * * *
it * - * * *
is * - * * *
not * - * * *
regulated * regulate * (V*) *
correctly * - * * *
: * - * * *
its * - * * *
subcellular * - * * *
localization * - * * *
and * - * * *
transcriptional * - * * *
function * - * * *
are * - * * *
not * - * * *
affected * - * * *
by * - * * *
stimulation * stimulate * * (V*)
of * - * * *
the (ORG* - * * (A0*
COS * - * * *
cells *) - * * *)
with * - * * *
ionomycin (EXP*) - * * (A1*)
and * - * * *
phorbol (EXP* - * * *
12-myristate * - * * *
13-acetate *) - * * *
. * - * * *

The * - * * *
response * respond (V*) * *
of * - * * *
this (DNA* - (A1* * *
fusion *) - *) * *
to * - * * *
the (PTE* - (A0* * *
glp * - * * *
repressor *) - *) * *
was * - * * *
compared * - * * *
with * - * * *
those * - * * *
of * - * * *
fusion * - * * *
constructs * - * * *
in * - * * *
which * - * * *
O (DNA* - * (A0* *
( * - * * *
D * - * * *
) * - * * *
3 *) - * *) *
and * - * * *
O (DNA*) - * * *
( (DNA*) - * * *
D (DNA*) - * * *
) (DNA* - * * *
4 *) - * * *
were * - * * *
inactivated * inactivate * (V*) *
by * - * * *
either * - * * *
deletion (EXP*) - * (A1*) *
or * - * * *
site-directed * - * * (A5*)
mutagenesis * mutate * * (V*)
. * - * * *

Despite * - *
extensive * - *
overlap * - *
of * - *
regulatory * - *
elements * - *
, * - *
pnrfA (DNA* - (A0*
and * - *
pacsP1 *) - *)
are * - *
regulated * regulate (V*)
independently * - (A5*)
. * - *

Three * - *
distinct * - *
regions * - *
are * - *
protected * - *
by * - *
TorR (PTE*) - (A1*)
binding * bind (V*)
. * - *

Regulation * regulate (V*)
of * - *
the (DNA* - (A0*
Escherichia * - *
coli * - *
K-12 * - *
uvrB * - *
operon *) - *)
. * - *

Increasing * - * *
the * - * *
spacing * - * *
to * - * *
four * - * *
or * - * *
more * - * *
basepairs * - * *
abolished * - * *
NarP (PTE*) - (A1*) *
binding * bind (V*) *
and * - * *
significantly * - * *
reduced * - * *
NarL (PTE*) - * (A1*)
binding * bind * (V*)
. * - * *

The * - * *
absence * - * *
of * - * *
transcriptional * - * *
termination * - * *
signals * - * *
may * - * *
, * - * *
in * - * *
principle * - * *
, * - * *
allow * - * *
extension * extend (V*) *
of * - * *
the (DNA* - (A0* (A0*
transcripts *) - *) *)
initiated * initiate * (V*)
at * - * (A2*)
the * - * *
up-stream * - * *
promoter * - * *
( * - * *
mraZ1p (DNA*) - * *
) * - * *
even * - * *
to * - * *
the * - * *
furthest * - * *
down-stream * - * *
gene * - * *
( * - * *
envA * - * *
) * - * *
. * - * *

Using * - * *
ROMA * - * *
, * - * *
we * - * *
identified * - * *
176 (DNA* - (A0* *
operons *) - *) *
that * - * *
were * - * *
activated * activate (V*) *
by * - * *
CRP (PTE*) - (A1*) (A1*)
in * - (A10* *
vitro * - *) *
and * - * *
16 (DNA* - * (A0*
operons *) - * *)
that * - * *
were * - * *
repressed * repress * (V*)
. * - * *

When * - *
glnAp2 (DNA*) - (A0*)
is * - *
activated * activate (V*)
by * - *
NifA (PTE*) - (A1*)
, * - *
a * - *
similar * - *
inhibitory * - *
effect * - *
by * - *
CRP-cAMP * - *
is * - *
observed * - *
. * - *

Studies * - * *
with * - * *
strains * - * *
deleted * delete (V*) *
for * - * *
the (DNA* - (A0* *
micF * - * *
locus *) - *) *
showed * - * *
that * - * *
the * - * *
marA-dependent * - * (A5*)
reduction * reduce * (V*)
of * - * *
OmpF (PTE*) - * (A0*)
required * - * *
an (DNA* - * *
intact * - * *
micF * - * *
locus *) - * *
. * - * *

These * - * * *
data * - * * *
suggest * - * * *
that * - * * *
binding * - (A0* * *
of * - * * *
the (PTE* - * * *
NFKB2 * - * * *
subunit *) - * * *
to * - * * *
the (DNA* - * * *
HIV * - * * *
enhancer *) - *) * *
is * - * * *
facilitated * facilitate (V*) * *
by * - * * *
RelA (PTE*) - (A1*) * *
( * - * * *
p65 * - * * *
) * - * * *
and * - * * *
that * - * * *
this (PTE* - * * (A0*
NFKB2 * - * * *
( * - * * *
p49 * - * * *
) * - * * *
/p65 * - * * *
heterodimeric * - * * *
complex *) - * * *)
mediates * - * * *
transcriptional * - * (A5*) *
activation * activate * (V*) *
which * - * * *
is * - * * *
subject * - * * *
to * - * * *
regulation * regulation * * (V*)
by * - * * *
MAD-3 (PTE*) - * * (A1*)
. * - * * *

Expression * express (V*)
of * - *
the * - *
human * - *
Trm4 * - *
( * - *
hTrm4 (DNA*) - (A0*)
) * - *
cDNA * - *
in * - (A2*
yeast * - *)
partially * - *
complements * - *
the * - *
lack * - *
of * - *
the * - *
endogenous * - *
Trm4p * - *
enzyme * - *
. (ORG*) - *

Regulation * regulate (V*)
in * - (A2*
the (DNA* - *
rpoS * - *
regulon *) - *)
of * - *
Escherichia * - *
coli * - *
. * - *

Screening * - *
of * - *
colonies * - *
by * - *
fluorescence * - *
microscopy * - *
revealed * - *
numerous (None* - *
mutants *) - *
that * - *
exhibited * - *
interesting * - *
patterns * - *
of * - *
porin * - (A0*)
expression * express (V*)
. * - *

A * - *
mutational * - *
analysis * - *
, * - *
coupled * - *
with * - *
in * - *
vivo * - *
and * - *
in * - *
vitro * - *
transcription * - *
experiments * - *
, * - *
indicated * - *
that * - *
Lrp * - (A0*
sites * - *)
that * - *
overlap * - *
the * - *
dad * - *
promoters * - *
were * - *
involved * involve (V*)
in * - *
repression (PRC*) - (A4*)
. * - *

Electrophoretic * - * *
mobility * - * *
shift * - * *
assays * - * *
and * - * *
DNase * - * *
I * - * *
protection * - * *
assays * - * *
indicate * - * *
that * - * *
where * - * *
the * - * *
phosphorylated * - * *
form * - * *
of * - * *
the * - * *
ArcA * - * *
protein * - * *
( * - * *
ArcA-P (PTE*) - (A0*) *
) * - * *
is * - * *
expected * - * *
to * - * *
act * act (V*) *
as * - * *
a (PTE* - (A4* *
transcriptional * - * *
repressor *) - *) *
( * - * *
e * - * *
. * - * *
g * - * *
. * - * *
, * - * *
of * - * *
lctPRD * - * *
and * - * *
gltA-sdhCDAB * - * *
) * - * *
, * - * *
the * - * *
effect * - * *
is * - * *
likely * - * *
to * - * *
be * - * *
mediated * - * *
by * - * *
sequestration * sequestrate * (V*)
of * - * *
cis-controlling * - * (A0*
transcriptional * - * *
regulatory * - * *
elements * - * *)
. * - * *

However * - * * * *
, * - * * * *
overexpression * overexpression (V*) * * *
of * - * * * *
gcvR (DNA*) - (A0*) * * *
re-established * - * * * *
purine-mediated * - * (A5*) * *
repression * repress * (V*) * *
of * - * * * *
the (DNA* - * (A0* * *
gcvT * - * * * *
: * - * * * *
: * - * * * *
lacZ * - * * * *
fusion *) - * *) * *
, * - * * * *
supporting * - * * * *
the * - * * * *
model * - * * * *
for * - * * * *
gcv (DNA*) - * * (A0*) *
regulation * regulation * * (V*) *
that * - * * * *
suggests * - * * * *
the * - * * * *
need * - * * * *
for * - * * * *
a * - * * * *
relatively * - * * * *
constant * - * * * *
GcvA * - * * * *
to * - * * * *
GcvR * - * * * *
ratio * - * * * *
for * - * * * *
appropriate * - * * * *
regulation * - * * * *
of * - * * * *
gcv (DNA*) - * * * (A0*)
expression * express * * * (V*)
in * - * * * *
response * - * * * *
to * - * * * *
glycine * - * * * *
and * - * * * *
purine * - * * * *
availability * - * * * *
. * - * * * *

The * - *
combination * - *
of * - *
potent * - *
enhancer * - *
and * - *
governor * - *
sites * - *
at * - *
the * - *
glnAp2 * - *
promoter * - *
provides * - *
for * - *
efficient * - *
activation * activate (V*)
of * - *
the (DNA* - (A0*
promoter *) - *)
when * - *
the (PTE* - (A3*
activator * - *
concentration *) - *
is * - *
low * - *)
, * - *
while * - *
limiting * - *
the * - *
maximum * - *
level * - *
of * - *
promoter * - *
activity * - *
when * - *
the * - *
activator * - *
concentration * - *
is * - *
high * - *
. * - *

However * - *
, * - *
inactivation * inactivate (V*)
of * - *
mlrA (DNA*) - (A0*)
did * - *
not * - *
affect * - *
curli * - *
production * - *
and * - *
aggregative * - *
morphology * - *
in * - *
an * - *
upregulated * - *
curli * - *
producing * - *
S (None* - *
. * - *
typhimurium * - *
derivative *) - *
containing * - *
a * - *
temperature- * - *
and * - *
RpoS-independent * - *
agfD * - *
promoter * - *
region * - *
. * - *

Thus * - * *
, * - * *
MelR (PTE*) - (A1*) (A1*)
and * - * *
CRP (PTE*) - * *
activate * activate (V*) *
transcription (PRC*) - (A0*) *
by * - * *
a * - * *
novel * - * *
mechanism * - * *
in * - * *
which * - * *
they * - * *
bind * bind * (V*)
co-operatively * - * *
to * - * *
adjacent (DNA* - * (A7*
sites *) - * *)
and * - * *
form * - * *
a * - * *
bacterial * - * *
enhanceosome * - * *
. * - * *

Gene (DNA*) - (A0*)
expression * express (V*)
regulation * - *
by * - *
the (PTE* - *
Curli * - *
activator * - *
CsgD * - *
protein *) - *
: * - *
modulation * - *
of * - *
cellulose * - *
biosynthesis * - *
and * - *
control * - *
of * - *
negative * - *
determinants * - *
for * - *
microbial * - *
adhesion * - *
. * - *

Deletion * delete (V*) * *
of * - * * *
the (DNA* - (A0* * *
arcA * - * * *
gene *) - *) * *
caused * - * * *
about * - * * *
a * - * * *
2-fold * - * * *
increase * - * * *
in * - * * *
the * - * * *
ptsG (DNA*) - * (A0*) *
expression * express * (V*) *
, * - * * *
and * - * * *
overexpression * overexpression * * (V*)
of * - * * *
ArcA (PTE*) - * * (A0*)
significantly * - * * *
decreased * - * * *
glucose * - * * *
consumption * - * * *
. * - * * *

The (DNA* - (A1* * *
ompB * - * * *
operon *) - *) * *
encodes * encode (V*) * *
OmpR (PTE* - (A0* * *
and * - * * *
EnvZ *) - *) * *
, * - * * *
two * - * * *
proteins * - * * *
that * - * * *
are * - * * *
necessary * - * * *
for * - * * *
the * - * * *
expression * express * (V*) *
and * - * * *
osmoregulation * osmoregulate * * (V*)
of * - * * *
the (PTE* - * (A0* (A0*
OmpF * - * * *
and * - * * *
OmpC * - * * *
porins *) - * *) *)
in * - * (A2* (A2*
Escherichia (ORG* - * * *
coli *) - * *) *)
. * - * * *

Oxidative * - *
stress * - *
is * - *
suggested * - *
to * - *
occur * - *
in * - *
retinal * - *
tissue * - *
during * - *
age-related * - *
macular * - *
degeneration * - *
and * - *
diabetic * - *
retinopathy * - *
and * - *
is * - *
suspected * - *
in * - *
the * - *
mechanism * - *
of * - *
VEGF * - (A0*)
expression * express (V*)
in * - *
these * - *
diseases * - *
. * - *

We * - * *
identified * - * *
two * - * *
new * - * *
targets * - * *
of * - * *
this * - * *
complex * - * *
: * - * *
argG (DNA*) - (A1*) *
, * - * *
which * - * *
encodes * encode (V*) *
the (PTE* - (A0* *
arginosuccinate * - * *
synthase *) - *) *
involved * - * *
in * - * *
the * - * *
arginine * - * *
biosynthetic * - * *
pathway * - * *
, * - * *
and * - * *
metY (DNA*) - * (A1*)
, * - * *
which * - * *
encodes * encode * (V*)
one * - * *
of * - * *
the * - * *
two * - * *
methionine * - * *
tRNA * - * *
initiators * - * *
, * - * *
tRNAf2Met (PTE*) - * (A0*)
. * - * *

Binding * bind (V*) *
of * - * *
the (PTE* - (A1* *
TorR * - * *
regulator *) - *) *
to * - * *
cis-acting (DNA* - (A7* *
direct * - * *
repeats *) - *) *
activates * - * *
tor (DNA* - * (A0*
operon *) - * *)
expression * express * (V*)
. * - * *

In * - * *
this * - * *
study * - * *
, * - * *
uvrA (PRC* - (A0* *
gene * - * *
expression *) - *) *
was * - * *
repressed * repress (V*) *
when * - * *
ArcA (PTE*) - * (A0*)
was * - * *
induced * induce * (V*)
in * - * (A2*
E (ORG* - * *
. * - * *
coli *) - * *)
. * - * *

The (DNA* - (A1* (A1*
rpoS * - * *
gene *) - *) *)
, * - * *
encoding * encode (V*) *
a (PTE* - (A0* *
known * - * *
positive * - * *
regulator *) - *) *
of * - * *
curli * - * *
synthesis * - * *
, * - * *
and * - * *
the * - * *
E * - * *
. * - * *
coli * - * *
open * - * *
reading * - * *
frame * - * *
( * - * *
ORF * - * *
) * - * *
of * - * *
unknown * - * *
function * - * *
, * - * *
yehV (DNA*) - * *
, * - * *
identified * - * *
on * - * *
each * - * *
of * - * *
these * - * *
cosmids * - * *
, * - * *
respectively * - * *
, * - * *
conferred * confer * (V*)
curli * - * (A0*
production * - * *)
and * - * *
HA * - * *
to * - * *
E * - * *
. * - * *
coli * - * *
HB101 * - * *
. * - * *

Thus * - * *
, * - * *
FNR (PTE*) - (A1*) *
can * - * *
respond * respond (V*) *
to * - * *
not * - * *
only * - * *
O (EXP* - (A0* *
( * - * *
2 * - * *
) *) - *) *
, * - * *
but * - * *
also * - * *
NO (EXP*) - * *
, * - * *
with * - * *
major * - * *
implications * - * *
for * - * *
global (DNA* - * (A0*
gene *) - * *)
regulation * regulation * (V*)
in * - * (A2*
bacteria * - * *)
. (ORG*) - * *

Recombinant (PTE* - *
NFAT1 *) - *
can * - *
mediate * - *
transcription * transcription (V*)
of * - *
the (EXP* - (A0*
interleukin-2 *) - *)
, * - *
interleukin-4 (EXP*) - *
, * - *
tumor (EXP* - *
necrosis * - *
factor * - *
alpha *) - *
, * - *
and * - *
granulocyte-macrophage (DNA* - *
colony-stimulating * - *
factor * - *
promoters *) - *
in * - (A2*
T (ORG* - *
cells *) - *)
, * - *
suggesting * - *
that * - *
NFAT1 (PTE*) - *
contributes * - *
to * - *
the * - *
CsA-sensitive * - *
transcription * - *
of * - *
these (DNA* - *
genes *) - *
during * - *
the * - *
immune * - *
response * - *
. * - *

Overexpression * overexpress (V*) *
of * - * *
SNURF (PTE*) - (A0*) *
in * - (A2* *
cultured (ORG* - * *
mammalian * - * *
cells *) - *) *
enhanced * - * *
not * - * *
only * - * *
androgen * - * *
, * - * *
glucocorticoid * - * *
, * - * *
and * - * *
progesterone * - * *
receptor-dependent * - * *
transactivation * - * *
but * - * *
also * - * *
basal * - * *
transcription * transcription * (V*)
from * - * *
steroid-regulated (DNA* - * (A6*
promoters *) - * *)
. * - * *

The * - *
design * - *
of * - *
a * - *
new * - *
mutation * - *
model * - *
for * - *
active * - *
genes * - *
: * - *
expression * express (V*)
of * - *
the (DNA* - (A0*
Escherichia * - *
coli * - *
lac * - *
operon *) - *)
in * - *
mammalian (ORG* - (A2*
cells *) - *)
. * - *

We * - *
characterized * - *
the (DNA* - (A1*
gntT * - *
gene *) - *)
encoding * encode (V*)
a (PTE* - (A0*
high-affinity * - *
gluconate * - *
permease *) - *)
of * - *
Escherichia * - *
coli * - *
K-12 * - *
. * - *

Mar (None* - (A1*
( * - *
multiple * - *
antibiotic * - *
resistant * - *
) * - *
mutants *) - *)
of * - *
Escherichia * - *
coli * - *
express * express (V*)
chromosomally * - (A5*
mediated * - *)
resistance * - (A0*
to * - *
a * - *
variety * - *
of * - *
structurally * - *
unrelated * - *
hydrophilic * - *
and * - *
hydrophobic * - *
antibiotics * - *)
. * - *

The (DNA* - (A1*
UAS *) - *)
situated * - *
within * - *
IR1 * - *
is * - *
responsible * - *
for * - *
activation * activate (V*)
of * - *
the (DNA* - (A0*
hyc * - *
operon *) - *)
, * - *
that * - *
within * - *
IR2 * - *
for * - *
activation * - *
of * - *
the * - *
hyp * - *
operon * - *
. * - *

However * - *
, * - *
this * - *
minimal * - *
set * - *
of * - *
factors * - *
is * - *
not * - *
sufficient * - *
for * - *
transcription * - *
when * - *
the * - (A0*
DNA * - *
template * - *)
is * - *
packaged * package (V*)
into * - *
chromatin * - (A7*)
. * - *

Escherichia * - *
coli * - *
possesses * - *
two * - *
systems * - *
, * - *
GntI * - *
and * - *
GntII * - *
, * - *
for * - *
gluconate * - *
uptake * - *
and * - *
catabolism * - *
, * - *
whose (DNA* - (A0*
genes *) - *)
are * - *
regulated * regulate (V*)
by * - *
GntR (PTE*) - (A1*)
as * - *
a * - *
repressor * - *
and * - *
GntH (PTE*) - *
as * - *
an * - *
activator * - *
, * - *
respectively * - *
. * - *

ArgR-independent * - (A5*) *
induction * induce (V*) *
and * - * *
ArgR-dependent * - * (A5*)
superinduction * superinduce * (V*)
of * - * *
the (DNA* - (A0* (A0*
astCADBE * - * *
operon *) - *) *)
in * - (A2* (A2*
Escherichia (ORG* - * *
coli *) - *) *)
. * - * *

P1 * - *
transduction * transduction (V*)
of * - *
marA (DNA* - (A0*
: * - *
: * - *
Tn5 *) - *)
into * - *
a (None* - (A7*
Mar * - *
mutant *) - *)
partially * - *
restored * - *
OmpF * - *
levels * - *
. * - *

One * - *
component * - *
( * - *
hRPC39 (PTE*) - (A1*)
) * - *
of * - *
this * - *
subcomplex * - *
interacts * interact (V*)
physically * - *
with * - *
both * - *
hTBP (PTE*) - (A1*)
and * - *
hTFIIIB90 (PTE*) - *
, * - *
two * - *
subunits * - *
of * - *
human * - *
RNA * - *
Pol * - *
III * - *
transcription * - *
initiation * - *
factor * - *
IIIB * - *
. * - *

TFIIB (PTE*) - (A1*)
binds * bind (V*)
FREAC-2 (PTE*) - (A7*)
close * - *
to * - *
the * - *
cleft * - *
between * - *
its * - *
two * - *
globular * - *
domains * - *
. * - *

The (PTE* - (A1*
other * - *
IRF * - *
family * - *
proteins *) - *)
bind * bind (V*)
DNA (DNA*) - (A7*)
with * - *
a * - *
specificity * - *
related * - *
to * - *
but * - *
distinct * - *
from * - *
that * - *
of * - *
ISGF3 * - *
gamma * - *
. * - *

Although * - *
Stat2 (PTE*) - (A1*)
is * - *
a * - *
potent * - *
transactivator * - *
, * - *
it * - *
does * - *
not * - *
interact * interact (V*)
stably * - *
with * - *
DNA (DNA*) - (A1*)
in * - *
complex * - *
with * - *
p48 * - *
alone * - *
. * - *

Here * - *
we * - *
report * - *
that * - *
the (DNA* - *
murine * - *
PU * - *
. * - *
1 * - *
promoter *) - *
, * - *
as * - *
well * - *
as * - *
the (DNA* - *
human * - *
promoter *) - *
, * - *
demonstrate * - *
tissue-specific * - (A5*)
reporter (DNA* - (A0*
gene *) - *)
expression * express (V*)
in * - *
myeloid (ORG* - *
cell * - *
lines *) - *
but * - *
not * - *
in * - *
T * - *
cells * - *
and * - *
HeLa * - *
( * - *
non-hematopoietic * - *
cells * - *
) * - *
cells * - *
. * - *

The * - *
binding * bind (V*)
of * - *
GntR (PTE*) - (A1*)
to * - *
these * - (A7*
sites * - *)
was * - *
proven * - *
in * - *
vitro * - *
by * - *
gel * - *
redardation * - *
assays * - *
and * - *
in * - *
vivo * - *
by * - *
site-directed * - *
mutagenesis * - *
of * - *
the * - *
binding * - *
sites * - *
. * - *

Here * - *
, * - *
we * - *
present * - *
new * - *
evidence * - *
that * - *
the * - *
ubiquitously * - *
expressed * - *
isoform * - *
dynamin-2 * - *
( * - *
dyn2 (PTE*) - (A0*)
) * - *
can * - *
also * - *
function * function (V*)
in * - *
a * - (A4*
signal * - *
transduction * - *
pathway * - *
( * - *
s * - *)
) * - *
. * - *

Effects * - * *
of * - * *
nitrate * - * *
respiration * - * *
on * - * *
expression * express (V*) *
of * - * *
the (DNA* - (A0* (A1*
Arc-controlled * - * *
operons *) - *) *)
encoding * encode * (V*)
succinate (PTE* - * (A0*
dehydrogenase *) - * *)
and * - * *
flavin-linked (PTE* - * *
L-lactate * - * *
dehydrogenase *) - * *
. * - * *

We * - *
now * - *
show * - *
that * - *
NarL * - *
can * - *
displace * - *
IHF (PTE*) - (A1*)
bound * bound (V*)
at * - *
the (PTE* - (A7*
IHF * - *
I * - *
site *) - *)
, * - *
but * - *
IHF * - *
is * - *
unable * - *
to * - *
displace * - *
bound * - *
NarL * - *
. * - *

Regulation * - * *
of * - * *
expression * express (V*) *
of * - * *
the (DNA* - (A0* (A0*
divergent * - * *
ulaG * - * *
and * - * *
ulaABCDEF * - * *
operons *) - *) *)
involved * involve * (V*)
in * - * *
LaAscorbate * - * (A4*
dissimilation * - * *)
in * - * *
Escherichia (ORG* - * (A2*
coli *) - * *)
. * - * *

Expression * express (V*)
of * - *
a (DNA* - (A0*
lacZ * - *
reporter * - *
gene *) - *)
under * - *
the * - *
control * - *
of * - *
the * - *
copA * - *
promoter * - *
was * - *
approximately * - *
proportional * - *
to * - *
the * - *
concentration * - *
of * - *
cupric * - *
ions * - *
in * - *
the * - *
medium * - *
, * - *
but * - *
increased * - *
more * - *
rapidly * - *
in * - *
response * - *
to * - *
silver (EXP* - *
ion * - *
concentrations *) - *
. * - *

OmpR (PTE*) - (A1*) *
is * - * *
a * - * *
DNA-binding * - * *
protein * - * *
which * - * *
acts * act (V*) *
as * - * *
both * - * *
an (PTE* - (A8* *
activator *) - *) *
and * - * *
a (PTE* - * *
repressor *) - * *
to * - * *
control * - * *
ompF (DNA*) - * (A0*)
transcription * transcription * (V*)
. * - * *

Role * - *
of * - *
14-3-3 * - *
eta * - *
as * - *
a * - *
positive * - *
regulator * - *
of * - *
the * - (A5*
glucocorticoid * - *
receptor * - *
transcriptional * - *)
activation * activate (V*)
. * - *

We * - * *
show * - * *
that * - * *
expression * express (V*) *
of * - * *
hTAF (PTE*) - (A0* *
( * - * *
II * - * *
) * - * *
135 * - *) *
in * - (A2* *
mammalian * - * *
cells * - *) *
strongly * - * *
and * - * *
selectively * - * *
potentiates * - * *
transcriptional * - * (A5*)
stimulation * stimulate * (V*)
by * - * *
the * - * *
activation * - * *
function-2 * - * *
( * - * *
AF-2 (PTE*) - * (A1*)
) * - * *
of * - * *
the * - * *
retinoic * - * *
acid * - * *
, * - * *
thyroid * - * *
hormone * - * *
, * - * *
and * - * *
vitamin * - * *
D3 * - * *
receptors * - * *
( * - * *
RAR * - * *
, * - * *
TR * - * *
, * - * *
and * - * *
VDR * - * *
) * - * *
, * - * *
but * - * *
does * - * *
not * - * *
affect * - * *
the (PTE* - * *
AF-2s *) - * *
of * - * *
the * - * *
estrogen * - * *
( * - * *
ER * - * *
) * - * *
or * - * *
retinoid * - * *
X * - * *
( * - * *
RXR * - * *
) * - * *
receptors * - * *
. * - * *

Using * - *
the * - *
DNA-binding * - *
domain * - *
of * - *
androgen * - *
receptor * - *
( * - *
AR * - (A0*)
) * - *
as * - *
a * - *
bait * - *
in * - *
a * - *
yeast * - *
two-hybrid * - *
screening * - *
, * - *
we * - *
have * - *
identified * - *
a * - *
small * - *
nuclear * - *
RING * - *
finger * - *
protein * - *
, * - *
termed * - *
SNURF (PTE*) - (A0*)
, * - *
that * - *
interacts * interact (V*)
with * - *
AR * - *
in * - *
a * - *
hormone-dependent * - *
fashion * - *
in * - (A2*
both * - *
yeast * - *
and * - *
mammalian * - *
cells * - *)
. * - *

Instead * - * *
, * - * *
it * - * (A1*)
can * - * *
act * - * *
to * - * *
repress * - * *
the * - * *
transcription * transcription (V*) *
of * - * *
E2F (DNA* - (A0* *
responsive * - * *
genes *) - *) *
by * - * *
countering * counter * (V*)
the * - * (A0*
activity * - * *
of * - * *
the (PTE* - * *
other * - * *
E2F * - * *
complexes *) - * *)
via * - * *
a * - * *
pRB- * - * *
, * - * *
p107- * - * *
, * - * *
or * - * *
p130-independent * - * *
mechanism * - * *
. * - * *

We * - *
describe * - *
the * - *
cloning * - *
and * - *
sequence * - *
analysis * - *
of * - *
a * - *
nearly * - *
full-length * - *
cDNA * - *
as * - *
well * - *
as * - *
a (DNA* - (A1*
corresponding * - *
5 * - *
. * - *
2-kilobase * - *
pair * - *
genomic * - *
fragment *) - *)
encoding * encode (V*)
FREAC-4 (PTE*) - (A0*)
, * - *
a * - *
member * - *
of * - *
the * - *
forkhead * - *
family * - *
of * - *
transcription * - *
factors * - *
. * - *

The (PTE* - * *
cyclic * - * *
AMP-CRP * - * *
complex *) - * *
was * - * *
shown * - * *
to * - * *
stimulate * - * *
transcription * transcription (V*) *
from * - * *
Pmcc (DNA*) - (A6*) *
: * - * *
the * - * *
absence * - * *
of * - * *
CRP (PTE* - * *
or * - * *
cAMP *) - * *
in * - * *
crp (None* - * *
or * - * *
cya * - * *
mutant * - * *
cells *) - * *
strongly * - * *
decreased * - * *
the * - * *
level * - * *
of * - * *
P * - * *
( * - * *
mcc * - * *
) * - * *
-lac (DNA*) - * (A0*)
expression * express * (V*)
. * - * *

The * - *
results * - *
provide * - *
insight * - *
into * - *
a * - *
mechanism * - *
whereby * - *
altered (PRC*) - *
expression * express (V*)
of * - *
Bcl-3 (DNA*) - (A0*)
leads * - *
to * - *
tumorigenic * - *
potential * - *
. * - *

Previous * - *
studies * - *
indicated * - *
that * - *
its * - (A0*
complementary * - *
expression * - *)
together * - *
with * - *
MAP1B * - *
during * - *
nervous * - *
system * - *
development * - *
is * - *
regulated * regulate (V*)
at * - *
the (PRC* - (A4*
transcriptional * - *
level *) - *)
and * - *
that * - *
the (DNA* - *
mouse * - *
Map1A * - *
gene *) - *
is * - *
transcribed * - *
under * - *
the * - *
control * - *
of * - *
5' (DNA* - *
and * - *
intronic * - *
promoters *) - *
. * - *

To * - * *
assess * - * *
the * - * *
possible * - * *
effects * - * *
of * - * *
HBV * - * *
regulatory * - * *
sequences * - * *
( * - * *
e * - * *
. * - * *
g * - * *
. * - * *
, * - * *
the * - * *
enhancer * - * *
) * - * *
on * - * *
expression * express (V*) *
of * - * *
neighboring (DNA* - (A0* *
host * - * *
genes *) - *) *
we * - * *
have * - * *
screened * - * *
for * - * *
cellular (DNA* - * (A0*
genes *) - * *)
that * - * *
are * - * *
both * - * *
overexpressed * overexpress * (V*)
and * - * *
adjacent * - * *
to * - * *
integrated * - * *
HBV * - * *
sequences * - * *
in * - * (A2*
hepatocellular (ORG* - * *
carcinoma * - * *
cells *) - * *)
. * - * *

Northern * - *
blot * - *
analysis * - *
revealed * - *
that * - *
a * - (A0*
1 * - *
. * - *
9-kb * - *
band * - *
of * - *
human (DNA* - *
SOX18 * - *
messenger * - *
RNAs *) - *)
was * - *
predominantly * - (A5*)
expressed * express (V*)
in * - *
heart * - (A4*)
, * - *
although * - *
weak * - *
signals * - *
were * - *
seen * - *
in * - *
brain * - *
, * - *
liver * - *
, * - *
testis * - *
, * - *
and * - *
leukocyte * - *
. * - *

The (DNA* - (A1*
gene *) - *)
encodes * encode (V*)
a (PTE* - (A0*
predicted * - *
protein * - *
of * - *
520 * - *
amino * - *
acids *) - *)
that * - *
is * - *
47 * - *
amino * - *
acids * - *
longer * - *
at * - *
the * - *
carboxy * - *
end * - *
than * - *
the * - *
highly * - *
related * - *
PAX3 * - *
protein * - *
. * - *

This * - *
order * - *
of * - *
affinities * - *
is * - *
the * - *
reverse * - *
of * - *
that * - *
of * - *
GalR (PTE*) - (A1*)
, * - *
which * - *
binds * bind (V*)
most * - *
strongly * - *
to * - *
the (DNA* - (A0*
operator *) - *
of * - *
galP * - *)
and * - *
most * - *
weakly * - *
to * - *
that * - *
of * - *
mgl * - *
. (DNA*) - *

The (DNA* - (A1*
gene * - *
yjfQ *) - *)
encodes * encode (V*)
the (PTE* - (A0*
repressor *) - *)
of * - *
the * - *
yjfR-X * - *
regulon * - *
( * - *
ula * - *
) * - *
, * - *
which * - *
is * - *
involved * - *
in * - *
L-ascorbate * - *
metabolism * - *
in * - *
Escherichia * - *
coli * - *
. * - *

Collaborative * - (A5*)
regulation * regulation (V*)
of * - *
Escherichia * - (A0*
coli * - *
glutamate-dependent * - *
acid * - *
resistance * - *)
by * - *
two * - *
AraC-like * - *
regulators * - *
, * - *
GadX (PTE*) - (A1*)
and * - *
GadW (PTE*) - *
( * - *
YhiW * - *
) * - *
. * - *

By * - * *
combining * - * *
Taz (PTE*) - * (A1*)
with * - * *
a * - (A1* *
reporter * - * *
system * - *) *
that * - * *
expresses * express (V*) *
green * - * *
fluorescent * - * *
protein * - * *
( * - * *
GFP (PTE*) - (A0*) *
) * - * *
from * - * *
the (DNA* - (A6* *
ompC * - * *
promoter *) - *) *
, * - * *
we * - * *
were * - * *
able * - * *
to * - * *
examine * - * *
the * - * *
interaction * interact * (V*)
of * - * *
Taz * - * *
with * - * *
all (PTE* - * (A1*
20 * - * *
natural * - * *
amino * - * *
acids *) - * *)
. * - * *

Overexpression * overexpress (V*) * * *
of * - * * * *
yhiE (DNA*) - (A0*) * * *
, * - * * * *
similarly * - * * * *
to * - * * * *
overexpression * overexpression * (V*) * *
of * - * * * *
gadX (PTE*) - * (A0*) * *
, * - * * * *
a * - * * * *
known * - * * * *
regulator * - * * * *
of * - * * * *
glutamate (PTE* - * * (A0* *
decarboxylase *) - * * *) *
expression * express * * (V*) *
, * - * * * *
leads * - * * * *
to * - * * * *
increased * - * * * *
resistance * - * * * *
of * - * * * *
E * - * * * *
. * - * * * *
coli * - * * * *
strains * - * * * *
under * - * * * *
high * - * * * *
acid * - * * * *
conditions * - * * * *
, * - * * * *
suggesting * - * * * *
that * - * * * *
YhiE * - * * * *
is * - * * * *
a * - * * * *
regulator * - * * * *
of * - * * * *
gene (DNA*) - * * * (A0*)
expression * express * * * (V*)
in * - * * * *
the * - * * * (A12*
acid * - * * * *
response * - * * * *)
. * - * * * *

Lrp (PTE*) - (A1*)
binds * bind (V*)
specifically * - (A5*)
to * - *
the (DNA* - (A7*
intergenic * - *
region *) - *)
between * - *
micF * - *
and * - *
ompC * - *
, * - *
as * - *
indicated * - *
by * - *
mobility * - *
shift * - *
assays * - *
and * - *
by * - *
DNase * - *
I * - *
footprinting * - *
. * - *

This * - * *
opposite * - * *
regulation * - * *
of * - * *
the * - * *
transcription * transcription (V*) *
of * - * *
the (DNA* - (A0* *
two * - * *
HU * - * *
genes *) - *) *
is * - * *
reflected * - * *
at * - * *
the * - * *
protein * - * *
level * - * *
signifying * - * *
that * - * *
changes * change * (V*)
in * - * *
the * - * (A0*
composition * - * *)
of * - * *
HU * - * *
occur * - * *
upon * - * *
changes * - * *
in * - * *
the * - * *
environment * - * *
. * - * *

A (None* - * (A0*
mutant * - * *
strain *) - * *)
of * - * *
E * - * *
. * - * *
coli * - * *
displaying * - * *
altered * - * *
regulation * regulation (V*) *
of * - * *
the (DNA* - (A0* *
recA * - * *
gene *) - *) *
was * - * *
isolated * isolate * (V*)
as * - * *
a * - * (A4*
revertant * - * *
of * - * *
a (None* - * *
lexA3 * - * *
recA200 * - * *
double * - * *
mutant *) - * *
which * - * *)
showed * - * *
improved * - * *
DNA * - * *
repair * - * *
and * - * *
recombination * - * *
functions * - * *
. * - * *

Recently * - * *
, * - * *
it * - * *
has * - * *
been * - * *
proposed * - * *
that * - * *
ligand-activated * - * *
degradation * - * *
of * - * *
GR (PTE*) - (A0*) *
occurs * - * *
via * - * *
the * - * *
ubiquitin-proteasomal * - * *
degradation * - * *
pathway * - * *
and * - * *
that * - * *
inhibition * - (A1*) (A1*)
of * - * *
proteasomal * - * *
activity * - * *
induces * - * *
up-regulation * upregulate (V*) *
of * - * *
GR (PTE*) - * *
and * - * *
enhances * enhance * (V*)
the * - * (A0*
transcriptional * - * *
activity * - * *
of * - * *
GR * - * *)
. * - * *

In * - * * *
Escherichia * - * * *
coli * - * * *
, * - * * *
the (PTE* - (A0* * *
transcription * - * * *
factor * - * * *
sigma * - * * *
s *) - *) * *
, * - * * *
encoded * encode (V*) * *
by * - * * *
rpoS (DNA*) - (A1*) * *
, * - * * *
controls * - * * *
the * - * * *
expression * express * (V*) *
of * - * * *
a * - * * *
large * - * * *
number * - * * *
of * - * * *
genes (DNA*) - * (A0*) (A1*)
involved * involve * * (V*)
in * - * * *
cellular * - * * (A8*
responses * - * * *)
to * - * * *
a * - * * *
diverse * - * * *
number * - * * *
of * - * * *
stresses * - * * *
, * - * * *
including * - * * *
starvation * - * * *
, * - * * *
osmotic * - * * *
stress * - * * *
, * - * * *
acid * - * * *
shock * - * * *
, * - * * *
cold * - * * *
shock * - * * *
, * - * * *
heat * - * * *
shock * - * * *
, * - * * *
oxidative * - * * *
DNA * - * * *
damage * - * * *
, * - * * *
and * - * * *
transition * - * * *
to * - * * *
stationary * - * * *
phase * - * * *
. * - * * *

Expression * - * *
, * - * *
cellular * - * *
localization * - * *
and * - * *
in * - * *
vitro * - * *
transcription (PRC*) - * (A0*)
studies * - * *
establish * - * *
that * - * *
cloned (PTE* - (A1* *
hUBF *) - *) *
encodes * encode (V*) *
a * - (A0* *
nucleolar * - * *
factor * - *) *
that * - * *
binds * - * *
specifically * - * *
to * - * *
the (DNA* - * *
upstream * - * *
control * - * *
element * - * *
and * - * *
core *) - * *
of * - * *
the (DNA* - * *
rRNA * - * *
gene * - * *
promoter *) - * *
to * - * *
activate * activate * (V*)
transcription * - * *
in * - * *
a * - * (A5*
binding * - * *
site-dependent * - * *
manner * - * *)
. * - * *

Unlike * - *
Rev-Erb * - *
, * - *
in * - *
which * - *
the (DNA* - (A1*
opposite * - *
strand *) - *)
of * - *
the * - *
C-terminal * - *
coding * - *
region * - *
encodes * encode (V*)
the (PTE* - (A0*
C-terminal * - *
portion *) - *)
of * - *
a * - *
variant * - *
thyroid * - *
hormone * - *
receptor * - *
isoform * - *
, * - *
the * - *
opposite * - *
strand * - *
of * - *
the * - *
C-terminal * - *
coding * - *
region * - *
of * - *
BD73 * - *
does * - *
not * - *
have * - *
any * - *
extensive * - *
open * - *
reading * - *
frames * - *
. * - *

The * - *
SRY (DNA*) - (A1*)
( * - *
sex-determining * - *
region * - *
Y * - *
) * - *
gene * - *
encodes * encode (V*)
a (PTE* - (A0*
transcription * - *
factor *) - *)
characterized * - *
by * - *
a * - *
DNA-binding * - *
motif * - *
termed * - *
the * - *
HMG * - *
( * - *
high * - *
mobility * - *
group * - *
) * - *
domain * - *
. * - *

Upon * - *
return * - *
to * - *
permissive * - *
temperature * - *
( * - *
30 * - *
degrees * - *
C * - *
) * - *
, * - *
the (DNA* - (A0*
transcripts *) - *)
reappeared * reappear (V*)
coordinately * - *
about * - *
15 * - *
min * - *
after * - *
the * - *
first * - *
synchronized * - *
initiation * - *
and * - *
then * - *
declined * - *
sharply * - *
again * - *
10 * - *
min * - *
later * - *
, * - *
just * - *
before * - *
the * - *
second * - *
initiation * - *
. * - *

We * - *
argue * - *
that * - *
, * - *
in * - *
the * - *
presence * - *
of * - *
melibiose (EXP*) - (A3*)
, * - *
this * - *
loop * - *
is * - *
broken * - *
as * - *
the (DNA* - (A0*
melAB * - *
promoter *) - *)
is * - *
activated * activate (V*)
. * - *

To * - *
decipher * - *
the * - *
mechanism * - *
of * - *
Rb * - *
function * - *
at * - *
the * - *
molecular * - *
level * - *
, * - *
we * - *
have * - *
systematically * - *
characterized * - *
a * - *
number * - *
of * - *
Rb-interacting * - *
proteins * - *
, * - *
among * - *
which * - *
is * - *
the (DNA* - (A1*
clone * - *
C5 *) - *)
described * - *
here * - *
, * - *
which * - *
encodes * encode (V*)
a (PTE* - (A0*
protein * - *
of * - *
1 * - *
, * - *
978 * - *
amino * - *
acids *) - *)
with * - *
an * - *
estimated * - *
molecular * - *
mass * - *
of * - *
230 * - *
kDa * - *
. * - *

Recombinant (PTE* - *
ISGF3 * - *
gamma *) - *
, * - *
like * - *
the * - *
natural * - *
protein * - *
, * - *
interacted * - *
with * - *
HeLa (PTE* - *
cell * - *
ISGF3 * - *
alpha *) - *
to * - *
form * form (V*)
the (PTE* - (A0*
mature * - *
ISGF3 * - *
DNA-binding * - *
complex *) - *)
. * - *

IHF (PTE*) - (A1*) (A1*)
binds * bind (V*) *
to * - * *
ompC (DNA* - (A7* *
DNA *) - *) *
and * - * *
protects * protect * (V*)
a (DNA* - * (A0*
region *) - * *)
of * - * *
35 * - * *
base * - * *
pairs * - * *
located * - * *
upstream * - * *
from * - * *
the * - * *
ompC * - * *
promoters * - * *
. * - * *

Gluconate-specific * - (A0* *
uptake * - * *
activity * - *) *
was * - * *
observed * - * *
with * - * *
cells * - * *
harboring * - * *
the * - * *
gntT * - * *
plasmid * - * *
clone * - * *
, * - * *
which * - * *
was * - * *
enhanced * enhance (V*) *
by * - * *
the * - (A1* *
presence * - * *
of * - * *
gntK * - *) *
encoding * encode * (V*)
gluconate (PTE* - * (A0*
kinase *) - * *)
. (DNA*) - * (A1*)

The (PTE* - * (A1*
leucine-responsive * - * *
regulatory * - * *
protein *) - * *)
of * - * *
Escherichia * - * *
coli * - * *
negatively * - * *
regulates * - * *
transcription * transcription (V*) *
of * - * *
ompC (DNA* - (A0* *
and * - * *
micF *) - *) *
and * - * *
positively * - * (A5*)
regulates * regulate * (V*)
translation * - * (A0*)
of * - * *
ompF * - * *
. * - * *

Binding * bind (V*) *
of * - * *
XylR (PTE*) - (A1*) *
to * - * *
the (DNA* - (A7* *
xyl * - * *
promoter *) - *) *
was * - * *
enhanced * - * *
by * - * *
the * - * *
presence * - * *
of * - * *
D-xylose (EXP*) - * *
, * - * *
suggesting * - * *
that * - * *
transcription (PRC*) - * (A0*)
was * - * *
positively * - * (A5*)
regulated * regulate * (V*)
by * - * *
XylR (PTE*) - * (A1*)
. * - * *

Features * - * *
of * - * *
the (None* - (A0* *
strain *) - *) *
carrying * carry (V*) *
the (DNA* - (A4* *
cpxA101 * - * *
mutation *) - *) *
are * - * *
a * - * *
reduced * - * *
ability * - * *
to * - * *
form * - * *
biofilm * - * *
and * - * *
low * - * *
levels * - * *
of * - * *
csgA (DNA*) - * (A0*)
transcription * transcription * (V*)
. * - * *

The (DNA* - (A1*
two * - *
MelR * - *
binding * - *
sites *) - *)
required * require (V*)
for * - *
this (PRC* - (A11*
optimal * - *
repression *) - *)
are * - *
separated * - *
by * - *
177 * - *
bp * - *
. * - *

In * - *
addition * - *
, * - *
eleven (DNA* - *
mutants *) - *
partially * - *
affected * - *
activin (PTE*) - (A0*)
binding * bind (V*)
to * - *
ALK4 * - *
. * - *

As * - *
the * - *
governor * - *
sites * - *
are * - *
themselves * - *
far * - *
from * - *
the * - *
promoter * - *
, * - *
they * - *
apparently * - *
act * - *
either * - *
by * - *
preventing * - *
the * - *
formation * - *
of * - *
the * - *
activation * - *
DNA * - *
loop * - *
that * - *
brings * - *
the * - *
enhancer-bound (PTE* - (A1*
activator *) - *)
and * - *
the * - *
promoter-bound * - *
polymerase (PTE*) - *
into * - *
proximity * - *
or * - *
by * - *
preventing * - *
a * - *
productive * - *
interaction * interact (V*)
between * - *
the * - *
enhancer-bound * - *
activator * - *
and * - *
polymerase * - *
. * - *

Thus * - *
this * - *
effect * - *
of * - *
iron * - *
was * - *
also * - *
seen * - *
in * - *
a * - *
sodA * - *
: * - *
: * - *
lacZ * - *
operon * - *
fusion * - *
in * - *
which * - *
the * - (A0*
production * - *)
of * - *
beta-galactosidase * - *
was * - *
regulated * regulate (V*)
by * - *
the (DNA* - (A1*
sodA * - *
promoter *) - *)
. * - *

Several * - * *
other * - * *
genes * - * *
including * - * *
the (DNA* - (A1* *
sdhA-D *) - * *
, * - * *
sucA-D * - *) *
, * - * *
and * - * *
fumA (DNA* - * *
genes *) - * *
, * - * *
encoding * encode (V*) *
key * - (A0* *
constituents * - * *
of * - * *
the * - * *
Krebs * - * *
cycle * - *) *
, * - * *
proved * - * *
to * - * *
be * - * *
repressed * - * *
by * - * *
the * - * *
loss * lose * (V*)
of * - * *
both (PTE* - * (A0*
transcription * - * *
factors *) - * *)
. * - * *

PA-coenzyme * - *
A * - *
( * - *
PA-CoA (PTE*) - *
) * - *
, * - *
but * - *
not * - *
PA * - *
, * - *
specifically * - *
inhibited * - *
binding * bind (V*)
of * - *
PaaX (PTE*) - (A1*)
to * - *
the (DNA* - (A7*
target * - *
sequences *) - *)
, * - *
thus * - *
confirming * - *
the * - *
first * - *
intermediate * - *
of * - *
the * - *
pathway * - *
as * - *
the * - *
true * - *
inducer * - *
and * - *
PaaX * - *
as * - *
the * - *
only * - *
bacterial * - *
regulatory * - *
protein * - *
described * - *
so * - *
far * - *
that * - *
responds * - *
to * - *
an * - *
aryl-CoA * - *
compound * - *
. * - *

We * - *
show * - *
that * - *
the (PTE* - (A1*
cAMP-CRP * - *
activator * - *
complex *) - *)
recognizes * recognize (V*)
two (DNA* - (A0*
sites *) - *)
in * - (A2*
tsx-p2 * - *)
that * - *
are * - *
separated * - *
by * - *
33 * - *
bp * - *
: * - *
a * - *
high-affinity * - *
site * - *
( * - *
CRP-1 * - *
) * - *
overlaps * - *
the * - *
-35 * - *
region * - *
, * - *
and * - *
a * - *
low-affinity * - *
site * - *
( * - *
CRP-2 * - *
) * - *
is * - *
centered * - *
around * - *
position * - *
-74 * - *
bp * - *
. (DNA*) - *

Alteration * - * *
by * - * *
base (DNA*) - (A0*) *
substitutions * substitute (V*) *
of * - * *
any (DNA* - * *
of * - * *
the * - * *
four * - * *
tor * - * *
boxes *) - * *
in * - * *
a (DNA* - * *
plasmid *) - * *
containing * - * *
a (DNA* - * *
torC'-lacZ * - * *
fusion *) - * *
dramatically * - * *
reduces * - * *
TorR-dependent * - * (A5*)
torC (DNA*) - * (A0*)
expression * express * (V*)
. * - * *

These * - *
results * - *
suggest * - *
that * - *
the (PTE* - *
response * - *
regulator * - *
ArcA *) - *
regulates * - *
expression * express (V*)
of * - *
enzyme * - *
IICB * - *
( * - *
Glc (PTE*) - (A0*)
) * - *
mediating * - *
the * - *
first * - *
step * - *
of * - *
glucose * - *
metabolism * - *
in * - *
response * - *
to * - *
the * - *
redox * - *
conditions * - *
of * - *
growth * - *
in * - *
E * - *
. * - *
coli * - *
. * - *

Coexpression * - (A1*
of * - *
wild-type * - *
Rb * - *)
, * - *
but * - *
not * - *
mutant * - *
Rb * - *
that * - *
fails * - *
to * - *
bind * - *
to * - *
Trip230 * - *
, * - *
inhibits * inhibit (V*)
such (PRC* - (A0*
activity *) - *)
. * - *

We * - * *
recently * - * *
cloned * - * *
murine (DNA* - (A1* *
and * - * *
human * - * *
cDNAs *) - *) *
that * - * *
encode * encode (V*) *
CP2 (PTE*) - (A0*) (A1*)
, * - * *
a * - * *
cellular * - * *
transcription * - * *
factor * - * *
that * - * *
interacts * interact * (V*)
with * - * *
the (DNA* - * (A1*
alpha-globin * - * *
promoter *) - * *)
as * - * *
well * - * *
as * - * *
with * - * *
additional (DNA* - * *
cellular * - * *
and * - * *
viral * - * *
promoter * - * *
elements *) - * *
. * - * *

The (DNA* - (A1* *
purR * - * *
gene *) - *) *
encodes * encode (V*) *
a * - * *
repressor * - * *
( * - * *
PurR (PTE*) - (A0*) *
) * - * *
controlling * - * *
the * - * *
synthesis * synthesize * (V*)
of * - * *
the (PTE* - * (A0*
enzymes *) - * *)
of * - * *
purine * - * *
biosynthesis * - * *
. * - * *

Because * - *
the * - *
metabolism * - *
of * - *
glucose * - *
polymers * - *
must * - *
be * - *
coordinated * - *
with * - *
both * - *
the * - *
anabolic * - *
and * - *
catabolic * - *
uses * - *
of * - *
glucose * - *
and * - *
glycogen * - *
, * - *
an * - *
intricate * - *
set * - *
of * - *
regulatory * - *
mechanisms * - *
controls * - *
the * - *
expression * express (V*)
of * - *
mal (DNA* - (A0*
genes *) - *)
, * - *
the * - *
activity * - *
of * - *
the * - *
maltose * - *
transporter * - *
, * - *
and * - *
the * - *
activities * - *
of * - *
the * - *
maltose/maltodextrin * - *
catabolic * - *
enzymes * - *
. * - *

In * - * *
addition * - * *
, * - * *
both * - * *
himA * - (A1* *
and * - * *
himD * - * *
lesions * - *) *
caused * cause (V*) *
a * - (A0* (A9*
sevenfold * - * *
reduction * - *) *)
in * - * *
expression * express * (V*)
of * - * *
a (DNA* - * (A0*
phi * - * *
( * - * *
fimA-lacZ * - * *
) * - * *
operon * - * *
fusion *) - * *)
in * - * (A2*
strains * - * *)
in * - * *
which * - * *
fimA * - * *
was * - * *
locked * - * *
in * - * *
the * - * *
on * - * *
phase * - * *
. (None*) - * *

Two * - *
different * - *
modes * - *
of * - *
transcription (PRC*) - (A5*)
repression * repress (V*)
of * - *
the (DNA* - (A0*
Escherichia * - *
coli * - *
acetate * - *
operon *) - *)
by * - *
IclR (PTE*) - (A1*)
. * - *

Affinity-purified (PTE* - (A1* *
human * - * *
TFIIIC *) - *) *
from * - * *
an * - * *
epitope-tagged * - * *
TFIIIC35 * - * *
cell * - * *
line * - * *
is * - * *
active * - * *
in * - * *
binding * bind (V*) *
to * - * *
and * - * *
in * - * *
transcription * transcription * (V*)
of * - * *
the (DNA* - (A7* (A0*
VA1 * - * *
gene *) - *) *)
in * - * (A5*
vitro * - * *)
. * - * *

Integration * - *
host * - *
factor * - *
( * - *
IHF * - *
) * - *
of * - *
Escherichia * - *
coli * - *
is * - *
a (PTE* - *
DNA-binding * - *
protein *) - *
involved * - *
in * - *
gene (DNA*) - (A0*)
expression * express (V*)
and * - *
other * - *
cellular * - *
functions * - *
in * - (A2*
E (ORG* - *
. * - *
coli *) - *)
and * - *
some * - *
of * - *
its (ORG* - *
bacteriophages * - *
and * - *
plasmids *) - *
. * - *

The * - *
magnitude * - *
of * - *
the * - *
synergistic * - *
effects * - *
was * - *
usually * - *
greater * - *
with * - *
just * - *
two * - *
activators * - *
than * - *
with * - *
all * - *
three * - *
, * - *
suggesting * - *
possible * - *
redundancies * - *
in * - *
the * - *
mechanisms * - *
of * - *
activation * activate (V*)
by * - *
CRP (PTE*) - (A1*)
, * - *
alpha-CTD (PTE*) - *
, * - *
and * - *
RhaR (PTE*) - *
. * - *

This * - *
study * - *
has * - *
shown * - *
that * - *
ArgR (PTE*) - (A1*)
does * - *
not * - *
act * act (V*)
as * - *
a (PTE* - (A8*
transcriptional * - *
repressor *) - *)
of * - *
P * - *
( * - *
cer * - *
) * - *
in * - *
plasmid * - *
monomers * - *
. * - *

Co-transfection (EXP*) - (A1*) * *
of * - * * *
PU (PTE* - * * (A1*
. * - * * *
1 *) - * * *)
or * - * * *
Spi-B * - * * *
in * - * * *
cells * - * * *
lacking * - * * *
PU * - * * *
. * - * * *
1 * - * * *
and * - * * *
Spi-B * - * * *
specifically * - * * *
transactivated * transactivate (V*) * *
a (DNA* - (A0* (A0* *
minimal * - * * *
promoter *) - *) *) *
containing * contain * (V*) *
the * - * (A4* *
PU * - * * *
. * - * * *
1 * - * * *
binding * - * * *
site * - * *) *
, * - * * *
indicating * - * * *
that * - * * *
PU * - * * *
. * - * * *
1 * - * * *
can * - * * *
activate * activate * * (V*)
its (DNA* - * * (A0*
own * - * * *
promoter * - * * *
elements *) - * * *)
in * - * * *
an * - * * (A5*
autoregulatory * - * * *
loop * - * * *)
. * - * * *

Thus * - *
far * - *
, * - *
the * - *
cAMP * - *
receptor * - *
protein * - *
( * - *
CRP * - *
) * - *
complex * - *
and * - *
Mlc * - *
are * - *
known * - *
to * - *
be * - *
the * - *
major * - *
regulators * - *
of * - *
ptsHIcrr (DNA*) - (A0*)
and * - *
ptsG (DNA*) - *
expression * express (V*)
in * - *
response * - *
to * - *
the * - (A3*
availability * - *)
of * - *
carbon * - *
sources * - *
. * - *

The * - *
leucine-responsive * - *
regulatory * - *
protein * - *
( * - *
Lrp (PTE*) - *
) * - *
acts * - *
as * - *
a (PTE* - *
specific * - *
repressor *) - *
for * - *
sigma * - *
s-dependent * - *
transcription * transcription (V*)
of * - *
the * - (A0*
Escherichia * - *
coli * - *
aidB * - *
gene * - *)
. * - *

In * - * * *
vitro * - * * *
footprinting * - * * *
showed * - * * *
that * - * * *
cyclic (PTE* - (A1* * *
AMP-CRP *) - *) * *
binds * bind (V*) * *
to * - * * *
a (DNA* - (A7* * *
34-bp * - * * *
site *) - *) * *
centered * - * * *
at * - * * *
-53 * - * * *
and * - * * *
at * - * * *
-75 * - * * *
in * - * * *
relation * - * * *
to * - * * *
the * - * * *
start * - * * *
sites * - * * *
of * - * * *
the (DNA* - * (A0* (A0*
major * - * * *
transcripts *) - * *) *)
that * - * * *
are * - * * *
inhibited * inhibit * (V*) *
and * - * * *
activated * activate * * (V*)
, * - * * *
respectively * - * * *
, * - * * *
by * - * * *
this (PTE* - * (A1* (A1*
complex *) - * *) *)
. * - * * *

We * - * *
have * - * *
isolated * - * *
a (DNA* - (A1* *
full-length * - * *
cDNA *) - *) *
encoding * encode (V*) *
a * - * *
protein * - * *
( * - * *
ATBF1 (PTE*) - (A0*) (A1*)
) * - * *
that * - * *
binds * bind * (V*)
to * - * *
an (DNA* - * *
AT-rich * - * *
motif *) - * *
in * - * *
the * - * *
human * - * *
alpha-fetoprotein * - * *
gene * - * *
enhancer * - * *
. * - * *

At * - *
present * - *
, * - *
CytR * - *
has * - *
been * - *
shown * - *
to * - *
'fine * - *
tune' * - *
transcription * transcription (V*)
of * - *
two * - *
genes * - *
( * - *
rpoH (DNA*) - (A0*)
and * - *
ppiA (DNA*) - *
) * - *
that * - *
are * - *
connected * - *
with * - *
protein-folding * - *
activities * - *
. * - *

GadW (PTE*) - (A1*) (A1*)
clearly * - * *
represses * repress (V*) *
gadX (DNA*) - (A0*) *
and * - * *
, * - * *
in * - * *
situations * - * *
where * - * *
GadX (PTE*) - * (A3*
is * - * *
missing * - * *)
, * - * *
activates * activate * (V*)
gadA (DNA*) - * (A0*)
and * - * *
gadBC (DNA*) - * *
. * - * *

Available * - *
evidence * - *
indicates * - *
that * - *
under * - *
those * - *
conditions * - *
, * - *
the (DNA* - (A1*
upstream * - *
promoter * - *
region *) - *)
acts * act (V*)
as * - *
a * - (A0*
silencer * - *)
of * - *
the (DNA* - (A4*
downstream * - *
transcriptional * - *
start * - *
site *) - *)
. * - *

